2021 Natural Products & Bioactive Compounds Gordon Research Conference & Gordon Research Seminar
2021 Natural Products & Bioactive Compounds Gordon Research Conference & Gordon Research Seminar
批准号:
10310554
负责人:
Amber J Onorato
金额:
$0.3万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-01 至 2023-04-30
关键词:
AcademiaAcademyAchievementAmberApplied ResearchAtmosphereBacterial InfectionsBasic ScienceBiochemistryBiologicalBiologyBreathingChemistryClinical ResearchCollaborationsCommunitiesDevelopmentDisabled PersonsDisciplineEatingEnsureEquilibriumFacultyFemaleFosteringFundingFutureGoalsGovernmentHeadHealthHourHumanIndustrializationIndustryInstitutionInternationalInvestigationKentuckyLeadershipLearningMalignant NeoplasmsMentorshipMethodologyMolecularMolecular TargetMulti-Drug ResistanceNatural ProductsParticipantPathway interactionsPeer ReviewPharmaceutical ChemistryPharmaceutical PreparationsPharmacologic SubstancePlayPostdoctoral FellowPreparationRecording of previous eventsResearchResearch PersonnelRoleScienceScientistSiteSocial InteractionSocializationStudentsThinkingTimeUnderrepresented MinorityUniversitiesWomanWorkbioactive natural productscareerdemographicsdrug developmentdrug discoveryethnic minority populationexperiencegraduate studenthuman diseaseimprovedinnovationlecturesmeetingsmid-career facultynew technologynext generationpostersprofessorracial and ethnicrare genetic disorderrecruitrole modelscaffoldsocialstemsymposiumundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Natural products have consistently served as an inspiration for drug discovery and drug development. Their
unique and diverse molecular scaffolds have stimulated investigation of biosynthetic pathways, molecular
targets, and inspired new synthetic strategies, which allowed for their structural confirmation and preparation.
Collectively, these efforts have advanced the field and enabled the search for the next generation of drugs for
unmet human diseases such as multidrug resistant bacterial infections, cancers, and other rare genetic
diseases. Therefore, not surprisingly, approximately two-thirds of all marketed pharmaceuticals have natural
product origins. The overall objective of the 2021 meeting is to continue the tradition of featuring exceptional
presentations and discussions at the forefront of science in order to further advance the broad and constantly
evolving field of natural products. A unique and diverse group of scientists will be assembled that span
scientific disciplines, and stem from various experience levels, backgrounds, and demographics. Also,
collaborative and cross-disciplinary interactions among attendees will be encouraged and fostered, while also
incorporating the development of emerging scientists. Approximately, 30 lecture-style presentations will
highlight unpublished research and stimulate rigorious discussion. Complementary informal research
discussions, typically 75, will occur via interactive poster sessions in a relaxed, social setting. In addition, the
conference format provides significant opportunity for professional development and social interactions
between attendees. Therefore, the goal of this R13 application is to request partial funding for the Gordon
Research Conference (08/01/21 – 08/06/21) and associated Gordon Research Seminar (07/31/21 – 08/01/21)
on Natural Products and Bioactive Compounds at Proctor Academy in Andover, NH in order to recruit graduate
students, postdocs, early career scientists, women, and other underrepresented minorities to an excellent and
high quality scientific conference. The meeting will be chaired by Dr. Amber J. Onorato, a frequent attendee
and associate professor in the department of chemistry and biochemistry at Northern Kentucky University. The
vice-Chair will be Philip R. Kym, Executive Director and Head of the Medicinal Chemistry Leadership Team at
AbbVie, who was nominated by previous chairs and elected by conferees at the 2019 GRC (07/28/19 –
08/02/19).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金